Loading...
Review article: linaclotide for the management of irritable bowel syndrome with constipation
BACKGROUND: Irritable bowel syndrome with constipation (IBS-C) represents a significant burden to patients and healthcare systems due to its prevalence and lack of successful symptomatic resolution with established treatment options. Linaclotide 290 μg has recently been approved by the European Medi...
Na minha lista:
| Udgivet i: | Aliment Pharmacol Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BlackWell Publishing Ltd
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4305214/ https://ncbi.nlm.nih.gov/pubmed/24433216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.12604 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|